| |
|
Baseline
|
|
12 weeks
|
|
|
Variable
|
Group
|
Rest
|
Max
|
Rest
|
Max
|
|
HbA1c
(%)
|
CE
|
8.01 (.35)
|
8.07 (.36)
|
7.36 (.28)
††
|
7.37 (.30)
##
|
| |
WE
|
8.21 (.41)
|
8.37 (.43)
|
8.00 (.38)
|
7.91 (.40)
#
|
|
Insulin
(μU·dl-1)
|
CE
|
13.45 (2.53)
|
12.29 (1.72)
|
11.41 (1.87)
|
10.17 (1.02)
|
| |
WE
|
17.04 (4.76)
|
14.57 (3.24)
|
10.64 (1.49)
†
|
8.29 (1.10)
*
|
|
C-peptide (ng·dl-1)
|
CE
|
2.83 (.75)
|
2.63 (.74)
|
1.99 (.37)
|
1.84 (.34)
|
| |
WE
|
2.46 (.66)
|
2.46
(.62)
|
1.22 (.15)
†
|
.87 (.17)
# ψ
|
|
Glucose
(mg·dl-1)
|
CE
|
136.4 (8.8)
|
139.1 (8.0)
‡
|
129.3 (10.6)
|
140.0 (10.1)
*
|
| |
WE
|
121.3 (10.0)
|
126.4 (10.3)
|
119.8 (8.3)
|
113.9 (8.4)
|
|
HOMA-IR
|
CE
|
4.57 (.92)
|
4.19 (.58)
|
3.70 (.77)
|
3.49 (.39)
|
| |
WE
|
4.96 (1.26)
|
4.46 (.87)
|
3.26 (.57)
|
2.39 (.43)
#
|
† and †† denote p <
0.05 and 0.01 respectively, baseline rest (BR) vs. 12 weeks rest (TR),
‡ p < 0.05 baseline rest (BR) vs. baseline max
(BM), * p < 0.05 12 weeks rest (TR) vs. 12 weeks max (TM), # and
## denote p < 0.05 and 0.01 respectively, baseline max (BM) vs. 12
weeks max (TM),ψ p < 0.05 between groups.
|